BETi-211

BETi-211 Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD  
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Company Name: Nanjing Shizhou Biology Technology Co.,Ltd  
Tel: 025-85560043 15850508050
Email: cindy.huang@synzest.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

BETi-211 manufacturers

  • BETi-211
  • BETi-211 pictures
  • $2180.00
  • 2026-05-11
  • CAS:1995867-02-1
  • Purity:
  • Supply Ability: 10g
BETi-211 Basic information
Product Name:BETi-211
Synonyms:9H-Pyrimido[4,5-b]indol-4-amine, N-(3-cyclopropyl-1-ethyl-1H-pyrazol-5-yl)-7-(3,5-dimethyl-4-isoxazolyl)-6-methoxy-2-(methoxymethyl)-;BETi-211;BETi211,BETi 211
CAS:1995867-02-1
MF:C26H29N7O3
MW:487.55
EINECS:
Product Categories:
Mol File:1995867-02-1.mol
BETi-211 Structure
BETi-211 Chemical Properties
Safety Information
MSDS Information
BETi-211 Usage And Synthesis
DescriptionBETi-211 is a novel selective BET bromodomain inhibitor.
UsesBETi-211 is an orally active BET inhibitor (Ki: <1 nM). BETi-211 inhibits growth of triple-negative breast cancers (TNBC) cell lines with IC50 < 1 μM. BETi-211 degrades BET proteins and suppress tumor growth in xenograft breast tumors[1].
References[1] Bai L, et al. Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. Cancer Res. 2017 May 1;77(9):2476-2487. DOI:10.1158/0008-5472.CAN-16-2622
BETi-211 Preparation Products And Raw materials
Tag:BETi-211(1995867-02-1) Related Product Information
6-pentadecylsalicylic acid AU-15330 ARV-825 dBET1 ROLIPRAM BI 2536